Latest Past Webinars
April 14th, 2021 7:00pm – 8:00pm EDT REGISTER NOW For Patients - Free Virtual Seminar: CCM® Therapy for Heart Failure: Is it Right for You? Register below for a free, virtual seminar facilitated by a cardiologist/ electrophysiologist that will be covering the following topics: Heart failure: What causes it and what happens as a result […]
Heart Failure is a progressive condition, and medical management strategies for this patient population has evolved over the years. This program will introduce CCM® therapy, review the action mechanism, and how the treatment works at the myocardial level. The faculty will review the clinical safety data surrounding the therapy as well as the indications for use. Evaluation and screening of patients that continue to be symptomatic from their heart failure indications despite being on guideline-directed medical treatment continue to be a challenge on all levels. Our faculty will discuss screening best practices, from both an electrophysiology and heart failure perspective, and how to establish a baseline for patients while giving them access to CCM® therapy that they may qualify to undertake.
Heart Failure is a progressive condition and medical management strategies for this patient population has evolved over the years. Assessment of Heart Failure utilizing the NYHA Heart Failure Classification System and EF have been used to diagnose patients and assist providers with optimizing medications and device therapy. This lecture will discuss the fundamental elements to assessing your heart failure patient classification and to stratify them for therapy that it is available for them. The program will introduce CCM® therapy as an option for patients that have NYHA Stage III heart failure and remain symptomatic despite guideline medical therapy. The Optimizer® was designed to improve overall heart function and quality of life for patients. CCM® indications will be discussed as well as best practices for screening patients for HCPs to offer this therapy for patients that qualify for this technology.